BIOMANUFACTURING FEATURED ARTICLES
The ISPE's Drug Shortages Prevention Model revamps its predecessor, the more prescriptive Drug Shortages Prevention Plan, with a focus on 12 key performance areas.
-
Risk And Supply Chain Continuity Management: Biologics Industry Perspectives
We spoke to three long-standing members of BioPhorum’s Risk and Business Continuity Workstream about their companies’ approaches to risk management, supply chain continuity, and what they learned from the pandemic. Among them are Melinda McCants, senior resiliency officer at Amgen.
-
A Step-By-Step Guide To Cell Banking
Cell banking stands at the forefront of medical advancement. This guide delves into the steps involved in protecting these priceless resources, from cell collection and processing to storage and cell expansion.
-
Getting Genomic Medicines Ready For Prime Time
Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.
BIOMANUFACTURING WHITE PAPERS & CASE STUDIES
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks. Explore those concerns, here.
-
The Heroes Of Vaccine Development: Lipid Nanoparticles
Lipid nanoparticles (LNPs) have played a crucial role in COVID-19 vaccine development as efficient mRNA delivery systems, exhibiting versatility and effectiveness in accelerating the process.
-
Uninterrupted Supply To Meet Demand
Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.
-
How To Make The Best LNPs
There are various factors that require careful consideration throughout the process of formulating LNPs and utilizing them for successful mRNA delivery and translation.
-
Lowering The Lipids Barrier: The Key To Accelerating RNA-LNP Drug Development
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
Custom Formulation Solution Including An Animal-Origin Element
Explore the customized, multi-component solution designed to meet quality and packaging specifications, while including an animal-origin element, as well as a non-compendial component.